Last updated: June 14, 2026
Sponsor: University of Alabama at Birmingham
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Neoplasms
Cancer
Treatment
Navigator-delivered Home ePRO
Evaluate implementation of navigator-delivered Home ePRO for all cancer patients
Clinical Study ID
NCT04809740
IRB-300007406
5R01NR019058
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient Group:
Age ≥18
Cancer patients at participating institution
Receipt of chemotherapy, targeted therapy, and immunotherapy at participatinginstitution from 2019-2026.
Exclusion
Exclusion Criteria:
- Second opinion only at participating institution.
Study Design
Total Participants: 3090
Treatment Group(s): 2
Primary Treatment: Navigator-delivered Home ePRO
Phase:
Study Start date:
May 04, 2021
Estimated Completion Date:
February 28, 2027
Study Description
Connect with a study center
University of Alabama at Birmingham
Birmingham, Alabama 35249
United StatesSite Not Available
University of Alabama at Birmingham
Birmingham 4049979, Alabama 4829764 35249
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.